These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 30256417)
21. Mivacurium induce mast cell activation and pseudo-allergic reactions via MAS-related G protein coupled receptor-X2. Che D; Wang J; Ding Y; Liu R; Cao J; Zhang Y; Hou Y; An H; Gao Z; Zhang T Cell Immunol; 2018 Oct; 332():121-128. PubMed ID: 30121125 [TBL] [Abstract][Full Text] [Related]
22. Discovery and analysis the anti-pseudo-allergic components from Perilla frutescens leaves by overexpressed MRGPRX2 cell membrane chromatography coupled with HPLC-ESI-IT-TOF system. Yang L; Zeng Y; Wang J; Zhang Y; Hou Y; Qin Q; Ma W; Wang N J Pharm Pharmacol; 2020 Jun; 72(6):852-862. PubMed ID: 32141613 [TBL] [Abstract][Full Text] [Related]
24. Murepavadin, a Small Molecule Host Defense Peptide Mimetic, Activates Mast Cells Amponnawarat A; Chompunud Na Ayudhya C; Ali H Front Immunol; 2021; 12():689410. PubMed ID: 34248979 [No Abstract] [Full Text] [Related]
25. MRGPRX2 mediates immediate-type pseudo-allergic reactions induced by iodine-containing iohexol. Yuan F; Zhang C; Sun M; Wu D; Cheng L; Pan B; Li T; Che D Biomed Pharmacother; 2021 May; 137():111323. PubMed ID: 33524790 [TBL] [Abstract][Full Text] [Related]
26. Osthole, a Natural Plant Derivative Inhibits MRGPRX2 Induced Mast Cell Responses. Callahan BN; Kammala AK; Syed M; Yang C; Occhiuto CJ; Nellutla R; Chumanevich AP; Oskeritzian CA; Das R; Subramanian H Front Immunol; 2020; 11():703. PubMed ID: 32391014 [TBL] [Abstract][Full Text] [Related]
27. Mast cell-mediated hypersensitivity to fluoroquinolone is MRGPRX2 dependent. Liu R; Hu S; Zhang Y; Che D; Cao J; Wang J; Zhao T; Jia Q; Wang N; Zhang T Int Immunopharmacol; 2019 May; 70():417-427. PubMed ID: 30856392 [TBL] [Abstract][Full Text] [Related]
28. MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia. Navinés-Ferrer A; Serrano-Candelas E; Lafuente A; Muñoz-Cano R; Martín M; Gastaminza G Sci Rep; 2018 Aug; 8(1):11628. PubMed ID: 30072729 [TBL] [Abstract][Full Text] [Related]
29. Naturally Occurring Missense MRGPRX2 Variants Display Loss of Function Phenotype for Mast Cell Degranulation in Response to Substance P, Hemokinin-1, Human β-Defensin-3, and Icatibant. Alkanfari I; Gupta K; Jahan T; Ali H J Immunol; 2018 Jul; 201(2):343-349. PubMed ID: 29794017 [TBL] [Abstract][Full Text] [Related]
30. Imperatorin ameliorates mast cell-mediated allergic airway inflammation by inhibiting MRGPRX2 and CamKII/ERK signaling pathway. Wang N; Wang J; Zhang Y; Zeng Y; Hu S; Bai H; Hou Y; Wang C; He H; He L Biochem Pharmacol; 2021 Feb; 184():114401. PubMed ID: 33387483 [TBL] [Abstract][Full Text] [Related]
31. MRGPRX2 is essential for sinomenine hydrochloride induced anaphylactoid reactions. Liu R; Che D; Zhao T; Pundir P; Cao J; Lv Y; Wang J; Ma P; Fu J; Wang N; Wang X; Zhang T; Dong X; He L Biochem Pharmacol; 2017 Dec; 146():214-223. PubMed ID: 28987593 [TBL] [Abstract][Full Text] [Related]
32. MRGPRX2 activation in mast cells by neuromuscular blocking agents and other agonists: Modulation by sugammadex. Fernandopulle NA; Zhang SS; Soeding PF; Mackay GA Clin Exp Allergy; 2021 May; 51(5):685-695. PubMed ID: 33275825 [TBL] [Abstract][Full Text] [Related]
33. Thebaine induces anaphylactic reactions via the MRGPRX2 receptor pathway on mast cells. Lei P; Liu Y; Ding Y; Su X; Liang J; Chen H; Ma W Cell Immunol; 2022 May; 375():104514. PubMed ID: 35398603 [TBL] [Abstract][Full Text] [Related]
34. IL-33 and MRGPRX2-Triggered Activation of Human Skin Mast Cells-Elimination of Receptor Expression on Chronic Exposure, but Reinforced Degranulation on Acute Priming. Wang Z; Guhl S; Franke K; Artuc M; Zuberbier T; Babina M Cells; 2019 Apr; 8(4):. PubMed ID: 30979016 [TBL] [Abstract][Full Text] [Related]
35. Amelioration of Compound 48/80-Mediated Itch and LL-37-Induced Inflammation by a Single-Stranded Oligonucleotide. Dondalska A; Rönnberg E; Ma H; Pålsson SA; Magnusdottir E; Gao T; Adam L; Lerner EA; Nilsson G; Lagerström M; Spetz AL Front Immunol; 2020; 11():559589. PubMed ID: 33101278 [TBL] [Abstract][Full Text] [Related]
36. MRGPRX2 Is the Codeine Receptor of Human Skin Mast Cells: Desensitization through β-Arrestin and Lack of Correlation with the FcεRI Pathway. Babina M; Wang Z; Roy S; Guhl S; Franke K; Artuc M; Ali H; Zuberbier T J Invest Dermatol; 2021 May; 141(5):1286-1296.e4. PubMed ID: 33058860 [TBL] [Abstract][Full Text] [Related]
37. MRGPRX2 is negatively targeted by SCF and IL-4 to diminish pseudo-allergic stimulation of skin mast cells in culture. Babina M; Wang Z; Artuc M; Guhl S; Zuberbier T Exp Dermatol; 2018 Nov; 27(11):1298-1303. PubMed ID: 30091263 [TBL] [Abstract][Full Text] [Related]
38. Novel Insights on MRGPRX2-Mediated Hypersensitivity to Neuromuscular Blocking Agents And Fluoroquinolones. Elst J; Maurer M; Sabato V; Faber MA; Bridts CH; Mertens C; Van Houdt M; Van Gasse AL; van der Poorten MM; De Puysseleyr LP; Hagendorens MM; Van Tendeloo VF; Lion E; Campillo-Davo D; Ebo DG Front Immunol; 2021; 12():668962. PubMed ID: 34385999 [TBL] [Abstract][Full Text] [Related]
39. Isosalvianolic acid C-induced pseudo-allergic reactions via the mast cell specific receptor MRGPRX2. Lin Y; Wang J; Hou Y; Fu J; Wei D; Jia Q; Lv Y; Wang C; Han S; He L Int Immunopharmacol; 2019 Jun; 71():22-31. PubMed ID: 30875538 [TBL] [Abstract][Full Text] [Related]